Brief: VYNE Therapeutics Announces First Patent Granted For Novel BET Inhibitor Platform

YARROW BIOSCIENCE

07/12/2022 13:32

Dec 7 (Reuters) - Vyne Therapeutics Inc  VYNE.O :
    * VYNE THERAPEUTICS ANNOUNCES FIRST PATENT GRANTED FOR NOVEL
BET
INHIBITOR PLATFORM
    * VYNE THERAPEUTICS INC - GRANTED PATENT COVERS COMPOUND IN
VYNE'S
VYN201 PROGRAM AND HAS A 20-YEAR TERM THAT WILL EXPIRE IN APRIL
2040

Source text for Eikon:  ID:nGNX9PVvXH 
Further company coverage:  VYNE.O